News

Qilu Pharmaceutical (Hainan) was awarded “National technology innovation demonstration enterprises” in 2013

ABOUT US

News

Qilu Pharmaceutical (Hainan) was awarded “National technology innovation demonstration enterprises” in 2013

Release time：

2014-05-12

China Ministry of Industry and Information Technology and Ministry of Finance announced the list of "National technology innovation demonstration enterprises" in 2013.

80 enterprises were awarded in China and Qilu Pharmaceutical (Hainan) was the unique enterprise awarded in Hainan Province.

Qilu antibiotics obtained the first CEP certificate for cefprozil

Qilu ranked fairly high in China Pharmaceutical Industry in 2013

Related News

Qilu Launches First Generic Version of Invega Sustenna® (Paliperidone Palmitate Suspension for Injection) in China

2023-10-12

Qilu Pharmaceutical launched the first innovative drug in China

2023-09-01

Qilu Pharmaceutical Group Awarded as Socially Responsible Enterprises (Entrepreneurs) in 2022

2023-04-04

Qilu Pharmaceutical ranks No.5 in the list of "Top 100 Enterprises in Chinese Pharmaceutical Industry”

2022-12-19

Qilu Pharmaceutical ranked 5th among China's top 100 list

2022-07-18

The Most Socially Responsible Enterprises (Entrepreneurs) in 2021

2022-06-15

Qilu Pharmaceutical Awarded as the Best R&D Pipeline Pharmaceutical Company

2021-08-02

Qilu Pharmaceutical Ranked No. 9 among Top 100 Chinese Pharmaceutical Companies

2021-08-01

Qilu Pharmaceutical Acquired an Exclusive Right for the Development and Commercialization of Vicineum™ in Greater China

2021-07-31

Abiraterone Acetate Tablets exported to US

2020-01-20

Tel: +86-531-83127705, 83127704, 83127706, 83127711

Address: 8888 Lvyou Road, High-tech Zone, Jinan, 250104, China

Email：export@qilu-pharma.com

京ICP备10002622号-38

监督举报

亲爱的合作伙伴：

欢迎举报以下行为！

索贿、暗箱操纵招标、内定中标单位、员工或亲属参与公司业务往来牟取私利、偷工减料、以次充好、故意刁难供应商等行为。

举报电话：0531-83126898/55820713/83126871

举报邮箱：qljc@qilu-pharma.com

收信地址：山东省济南市历城区旅游路8888号

齐鲁制药集团审计监察部

采购平台技术专线

0531-55820865